| CEO Name | Sharvil Patel |
| Nationality | India |
| Net Worth Estimation | $1.2 billion |
Sharvil Patel's estimated net worth of around $1.2 billion primarily derives from his significant equity stake and executive role in Cadila Healthcare (Zydus Cadila), a major listed pharmaceutical company in India. His wealth is also influenced by the company's strong market capitalization, global revenue growth, and the Patel family's controlling interest in the business.
Sharvil Patel, CEO of Cadila Healthcare (Zydus Cadila), has an estimated net worth of $1,200,000,000, significantly exceeding the typical pharmaceutical CEO net worth range of $10,000,000 to $500,000,000. His wealth is around 140% higher than the maximum estimated net worth in this sector.
Business Category: Pharmaceutical
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 500000000 USD
Sharvil Patel Performance in Cadila Healthcare (Zydus Cadila)
Sharvil Patel, CEO of Cadila Healthcare (Zydus Cadila), demonstrates strategic leadership driving innovation and growth in the pharmaceutical sector. His decision-making emphasizes research-led product development and expansion into global markets, enhancing the company's competitive edge. Under his tenure, Zydus Cadila has strengthened its market position and financial performance, reflecting his impactful corporate governance.
Latest News
Zydus Cadila's CEO Sharvil Patel leads the company's extensive operations including manufacturing, vaccines, pharmaceuticals, and new innovations. Under his management, Zydus Lifesciences Ltd (formerly Cadila Healthcare) is focusing on expanding its portfolio, including DNA plasmid vaccines and biosciences, with strong financial performance and ongoing clinical developments. The company recently rebranded to reflect its broader life sciences focus and is preparing for key product launches and strategic growth.
http://www.business-standard.com/topic/zydus-cadila
Source: